Blood and tissue samples for cancer treatment research
Part of Cancer clinical trials.
This study collects blood and tumor tissue samples from people receiving immunotherapy to learn how well these treatments work and why some cancers stop responding. Your samples help researchers improve future cancer care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are willing to give a blood sample and at least one tumor tissue sample.
- You are about to start immunotherapy as part of a participating clinical trial, or you have already received immunotherapy and are having a biopsy or surgery.
- If you have already had immunotherapy, your cancer either did not respond at first or stopped responding after an initial response.
- You agree to provide a fresh tumor sample (biopsy or surgery) for research.
- If a fresh sample is not possible, you may provide stored tumor tissue (FFPE blocks or slides) if allowed by your center.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects tumor tissue and related blood tests from people who already need a biopsy or surgery as part of their usual care. Researchers use the samples to learn what drives the tumor and how the tumor environment may affect treatment, which could help develop future therapies.
This study collects samples (like tissue biopsies and imaging information) from people with certain cancers who are starting anti–PD-1/PD-L1 immunotherapy. It helps researchers gather material to study how these treatments work.
This study collects blood and tumor samples to understand how well cancer immunotherapy works and what side effects may happen. It mainly helps researchers by checking “immune markers” before treatment starts, while you receive planned immune checkpoint therapy.
This study collects tissue or other cancer-related samples to help researchers better understand cancer and develop better tests or treatments. You can join if you are being evaluated for or treated for cancer, and you agree to let your samples be used for research.
This study collects and stores blood/tissue samples (called biospecimens) to support immunotherapy research at the cancer center. If you may qualify, your samples help researchers test new immune-based cancer treatments.
This trial uses a special test on live tumor samples to see if it can predict how well immune checkpoint inhibitors (a type of immunotherapy) will work for different cancers. It may help doctors choose the best treatment for you.
Hear when a new Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.